Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 409.00
-5.00 (-1.21%)
Oct 6, 2026, 3:30 PM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 8.82 billion as of October 5, 2026. Its market cap has increased by 119.90% in one year.
Market Cap
8.82B
Enterprise Value
9.71B
Revenue
729.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
409.00
ChartMarket Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 8.82B, an increase of 90.67%. That is a compound annual growth rate of 3.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 8.82B | 29.48% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 10.77B |
| Kubota Pharmaceutical Holdings | 10.54B |
| StemRIM | 10.28B |
| K Pharma,Inc. | 8.87B |
| Nano Holdings | 8.71B |
| CellSeed | 8.49B |
| Kidswell Bio | 8.40B |
| OncoTherapy Science | 8.16B |